Subcutaneous Ig NextGen 16% in PID Patients

Clinical trial NCT00391131 · COMPLETED

Trial details

NCT number: NCT00391131
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency (PID)

Start date: 2007-04-01
Primary completion: 2009-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.